Wyeth to Add 150 New
Biotech Jobs in Massachusetts
Additional Biotech Manufacturing Suites to Open in 2006
Madison, N.J., June 5, 2006
Wyeth Pharmaceuticals, a division of Wyeth
(NYSE:WYE), announced today that it is adding 150 new positions to suppo
manufacturing operations of an additional biotech manufacturing suite at its biotech
campus in Andover, Massachusetts, beginning in May 2006. These new hires will be
made primarily in the areas of manufacturing and quality and engineering. This is
addition to the 50 new positions added in 2005 to support increased drug development
activities on the campus. With the addition of these positions, Wyeth will employ
approximately 2,800 people in Massachusetts between its research campus in Cambridge
and its Andover facility.
“We believe Massachusetts is a great place to work and we look forward to
expanding our workforce and continuing our tradition of manufacturing excellence and
outstanding quality while meeting new product demand,” says Christophe
r R. Perley,
Managing Director, Andover, Wyeth Biotech, TO&PS.
This expansion is prompted by increased demand for licensed products as well as
anticipated new pipeline products, which include biotech and vaccine therapeutics
manufactured at the Andover fa
cility. Biotech products are among the fastest growing at
Wyeth. The Company currently ranks fourth in the industry in global revenues and
worldwide biotech manufacturing capacity.
The 1.2 million square foot Wyeth Biotech Campus in Andover has more than
1,900 employees, including scientists, engineers and technical experts.
As one of the
largest biotech campuses in the state, Wyeth’s Andover site focuses
on development of
future biotech products and on the manufacture of approved biotech therapies.
Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of
women’s health care, cardiovascular disease, central nervous system, inflammation,
transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth
of the world’s largest research
driven pharmaceutical and health care products
companies. It is a leader in the discovery, development, manufacturing and marketing of
pharmaceuticals, vaccines, biotechnology products and non
improve the quality of life for people worldwide. The Company’s major divisions
include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal